XML 23 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Earnings (Loss)
Retained Earnings
Treasury Stock
Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2021   602,704          
Beginning balance at Dec. 31, 2021 $ 26,940 $ 1 $ 19,672 $ 77 $ 8,139 $ (1,094) $ 145
Beginning balance, Treasury stock (in shares) at Dec. 31, 2021           20,225  
Increase (Decrease) in Stockholders' Equity              
Net earnings (loss) 1,189       1,202   (13)
Other comprehensive (loss) earnings, net of tax (1,209)     (1,209)      
Common stock issued for employee benefit plans (in shares)   5,143          
Common stock issued for employee benefit plans 71   71        
Fair value of unvested equity awards in connection with acquisition 60   60        
Common stock repurchases (in shares)           (36,868)  
Common stock repurchases (3,096)   23     $ (3,119)  
Stock compensation expense 234   234        
Reclassification to non-redeemable 17           17
Divestiture of noncontrolling interest (14)           (14)
Dividend to noncontrolling interest (10)           (10)
Purchase of non-redeemable noncontrolling interest (1)           (1)
Ending balance (in shares) at Dec. 31, 2022   607,847          
Ending balance at Dec. 31, 2022 24,181 $ 1 20,060 (1,132) 9,341 $ (4,213) 124
Ending balance, Treasury stock (in shares) at Dec. 31, 2022           57,093  
Increase (Decrease) in Stockholders' Equity              
Net earnings (loss) 2,699       2,702   (3)
Other comprehensive (loss) earnings, net of tax 480     480      
Common stock issued for employee benefit plans (in shares)   7,444          
Common stock issued for employee benefit plans 44   44        
Common stock repurchases (in shares)           (23,714)  
Common stock repurchases (1,643)         $ (1,643)  
Stock compensation expense 216   216        
Purchase of redeemable noncontrolling interest (12)   (12)        
Purchase of non-redeemable noncontrolling interest $ (28)   (4)       (24)
Ending balance (in shares) at Dec. 31, 2023 534,484 615,291          
Ending balance at Dec. 31, 2023 $ 25,937 $ 1 20,304 (652) 12,043 $ (5,856) 97
Ending balance, Treasury stock (in shares) at Dec. 31, 2023 80,807         80,807  
Increase (Decrease) in Stockholders' Equity              
Net earnings (loss) $ 3,300       3,305   (5)
Other comprehensive (loss) earnings, net of tax 148     148      
Common stock issued for employee benefit plans (in shares)   4,904          
Common stock issued for employee benefit plans 46   46        
Common stock repurchases (in shares)           (43,481)  
Common stock repurchases (3,141)         $ (3,141)  
Stock compensation expense 212   212        
Divestiture of noncontrolling interest $ (2)           (2)
Ending balance (in shares) at Dec. 31, 2024 495,907 620,195          
Ending balance at Dec. 31, 2024 $ 26,500 $ 1 $ 20,562 $ (504) $ 15,348 $ (8,997) $ 90
Ending balance, Treasury stock (in shares) at Dec. 31, 2024 124,288         124,288